NCT05995301

Brief Summary

The goal of this clinical trial is to compare the postoperative analgesic efficacy of ultrasound-guided TAP block with Local Anesthetic Infiltration of ropivacaine in patients undergoing laparoscopic surgery. The main question it aims to answer is: • If Transversus Abdominis Plane block with Ropivacaine will produce long duration of analgesia than the Local Anesthetic Infiltration with ropivacaine after laparoscopic abdominal surgery .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 12, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 12, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 9, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 16, 2023

Completed
Last Updated

August 28, 2023

Status Verified

August 1, 2023

Enrollment Period

8 months

First QC Date

August 9, 2023

Last Update Submit

August 24, 2023

Conditions

Keywords

RopivacaineTAP BlockAnalgesiaLaparoscopic abdominal surgery

Outcome Measures

Primary Outcomes (1)

  • Duration of analgesia

    Visual analog scale at rest

    Time Frame: upto first 24 hour after intervention

Secondary Outcomes (1)

  • Duration of analgesia

    Time Frame: upto first 24 hour after intervention

Other Outcomes (3)

  • Time to first rescue analgesia

    Time Frame: upto first 24 hour after intervention

  • Total pethidine consumption

    Time Frame: upto first 24 hour after intervention

  • Total ketorolac consumption

    Time Frame: upto first 24 hour after intervention

Study Arms (2)

Group I

EXPERIMENTAL

Transversus Abdominis Plane block

Drug: Ropivacaine in Transversus abdominis plane

Group II

EXPERIMENTAL

Local infiltration

Drug: Ropivacaine in Local infiltration at port site

Interventions

This group received 20ml of Ropivacaine 0.2% Injectable Solution in bilateral transversus abdominis plane at the end of surgery

Group I

This group received local infiltration of 20ml of Ropivacaine 0.2% Injectable Solutionat port sites at the end of surgery

Group II

Eligibility Criteria

Age25 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients of either sex aged 25-70 years
  • ASA physical status I or II
  • Patient posted for elective abdominal laparoscopic surgery.

You may not qualify if:

  • Any absolute contraindications to peripheral nerve blockade
  • History of Hypersensitivity to Drugs
  • Uncontrolled Diabetes Mellitus, Renal Failure, Hepatic failure
  • History of neuromuscular or psychiatric disease
  • Patient receiving psychotropic drug, chronic analgesic therapy
  • Pregnancy
  • Patient weight less than 50 kg

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Academy of Medical Sciences

Kathmandu, Bagmati, 977, Nepal

Location

MeSH Terms

Conditions

Agnosia

Interventions

Ropivacaine

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Surendra Bhusal, MD

    NAMS Bir Hospital

    PRINCIPAL INVESTIGATOR
  • Brihaspati K C, MD

    NAMS Bir Hospital

    STUDY DIRECTOR
  • Kaushal Tamang, MD

    NAMS Bir Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Patients were randomly assigned to two groups having 50patients in each, by using a computer-generated table of random numbers which was enclosed in a sealed envelope and was opened by an anesthesia assistant who was not involved in the study.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Patients were randomly assigned to two groups having 50patients in each, by using a computer-generated table of random numbers which was enclosed in a sealed envelope and was opened by an anesthesia assistant who was not involved in the study.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 9, 2023

First Posted

August 16, 2023

Study Start

March 12, 2022

Primary Completion

November 12, 2022

Study Completion

February 25, 2023

Last Updated

August 28, 2023

Record last verified: 2023-08

Locations